<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:circular="https://rhnvrm.github.io/stock-market-circulars/ns"><channel><title>Aspira - Stock Market Circulars</title><link>https://rhnvrm.github.io/stock-market-circulars/tags/aspira/</link><description>Regulatory circulars from NSE, BSE, and SEBI with AI-powered summaries</description><generator>Hugo -- gohugo.io</generator><language>en-us</language><lastBuildDate>Mon, 13 Apr 2026 00:00:00 +0000</lastBuildDate><atom:link href="https://rhnvrm.github.io/stock-market-circulars/tags/aspira/feed.xml" rel="self" type="application/rss+xml"/><item><title>Offer to Buy – Acquisition Window (Takeover) for ASPIRA PATHLAB &amp; DIAGNOSTICS LTD – Live Activities Schedule</title><link>https://rhnvrm.github.io/stock-market-circulars/circulars/bse/2026/bse-2026-04-13-d098aa153085a475-offer-to-buy-acquisition-window-takeover-for-aspira-pathlab-diagnostics-ltd-live/</link><pubDate>Mon, 13 Apr 2026 08:01:19 +0000</pubDate><guid>https://rhnvrm.github.io/stock-market-circulars/circulars/bse/2026/bse-2026-04-13-d098aa153085a475-offer-to-buy-acquisition-window-takeover-for-aspira-pathlab-diagnostics-ltd-live/</guid><description>BSE announces the live activities schedule for the Offer to Buy (Takeover) acquisition window for ASPIRA PATHLAB &amp; DIAGNOSTICS LTD (ASPIRA), open from 15th April 2026 to 28th April 2026 at Rs. 55.00 per share for up to 26,76,180 equity shares.</description><circular:source>bse</circular:source><circular:category>trading</circular:category><circular:impact>high</circular:impact><circular:severity>high</circular:severity><circular:importance>high</circular:importance><circular:id>d098aa153085a475</circular:id><circular:pdfUrl>https://www.bseindia.com/downloads/UploadDocs/Notices/20260413-10/20260413-10.pdf</circular:pdfUrl><circular:stock>ASPIRA</circular:stock><category>offer-to-buy</category><category>acquisition-window</category><category>takeover</category><category>equity</category><category>trading-operations</category><category>aspira</category><category>otb</category><category>ibbs</category><content:encoded><![CDATA[<h2 id="summary">Summary</h2>
<p>BSE has announced the live activities schedule for the Offer to Buy (OTB) – Acquisition Window (Takeover) for <strong>ASPIRA PATHLAB &amp; DIAGNOSTICS LTD</strong> (Symbol: ASPIRA, Scrip Code: 540788, ISIN: INE500C01017). The offer window is open from Wednesday, 15th April 2026 to Tuesday, 28th April 2026, with an offer price of Rs. 55.00 per share for up to 26,76,180 equity shares.</p>
<h2 id="key-points">Key Points</h2>
<ul>
<li><strong>Security:</strong> ASPIRA PATHLAB &amp; DIAGNOSTICS LTD (ASPIRA), Scrip Code 540788, ISIN INE500C01017</li>
<li><strong>Offer Size:</strong> Up to 26,76,180 equity shares</li>
<li><strong>Offer Price:</strong> Rs. 55.00 per share</li>
<li><strong>Face Value:</strong> Rs. 10.00</li>
<li><strong>Market Lot:</strong> 1</li>
<li><strong>Opening Date:</strong> Wednesday, 15th April 2026</li>
<li><strong>Closing Date:</strong> Tuesday, 28th April 2026</li>
<li>Live OTB session bid offering runs 9:15 a.m. to 3:30 p.m. daily</li>
<li>Give-up/Take-up modifications allowed from 15th–27th April 2026 (9:15 a.m. to 3:30 p.m.)</li>
<li>Last day give-up (28th April): 9:15 a.m. to 3:30 p.m.; last day take-up: 9:15 a.m. to 4:00 p.m.</li>
<li>Modification and cancellation of bids: <strong>Not Allowed</strong></li>
</ul>
<h2 id="regulatory-changes">Regulatory Changes</h2>
<p>No new regulatory changes are introduced. This notice operationalises the existing OTB – Acquisition Window (Takeover) framework as per Exchange Notices 20150930-1 (dated 30 September 2015) and 20170203-29 (dated 3 February 2017).</p>
<h2 id="compliance-requirements">Compliance Requirements</h2>
<ul>
<li>Trading Members must ensure UCC of investors is registered and/or updated with the correct PAN Number and Category in the Exchange UCC database.</li>
<li>Trading Members may only bid for investors holding shares in demat form.</li>
<li>If no securities are accepted, no End of Issue files will be generated in the Extranet.</li>
<li>Members and Custodians should use the iBBS platform (<a href="https://ibbs.bseindia.com/">https://ibbs.bseindia.com/</a>) and RTRMS platform (<a href="https://rtrms.bseindia.com/">https://rtrms.bseindia.com/</a>) for bid submission.</li>
<li>Leased Line access available via <a href="https://ibbsll.bseindia.com/">https://ibbsll.bseindia.com/</a> and <a href="https://rtrmsll.bseindia.com/">https://rtrmsll.bseindia.com/</a>.</li>
<li>Extranet file access for bid acceptance confirmation available at <a href="https://member.bseindia.com/">https://member.bseindia.com/</a> (Internet) or <a href="https://memberll.bseindia.com/">https://memberll.bseindia.com/</a> (Leased Line).</li>
</ul>
<h2 id="important-dates">Important Dates</h2>
<table>
  <thead>
      <tr>
          <th>Event</th>
          <th>Date / Period</th>
      </tr>
  </thead>
  <tbody>
      <tr>
          <td>Offer Opening Date</td>
          <td>Wednesday, 15th April 2026</td>
      </tr>
      <tr>
          <td>Offer Closing Date</td>
          <td>Tuesday, 28th April 2026</td>
      </tr>
      <tr>
          <td>Bid Offering Period</td>
          <td>15th April 2026 – 28th April 2026 (9:15 a.m. – 3:30 p.m.)</td>
      </tr>
      <tr>
          <td>Give-up / Take-up (Modification)</td>
          <td>15th April 2026 – 27th April 2026 (9:15 a.m. – 3:30 p.m.)</td>
      </tr>
      <tr>
          <td>Last Day Give-up</td>
          <td>28th April 2026 (9:15 a.m. – 3:30 p.m.)</td>
      </tr>
      <tr>
          <td>Last Day Take-up</td>
          <td>28th April 2026 (9:15 a.m. – 4:00 p.m.)</td>
      </tr>
  </tbody>
</table>
<h2 id="impact-assessment">Impact Assessment</h2>
<p>This circular directly impacts shareholders and trading/custodian members dealing in ASPIRA PATHLAB &amp; DIAGNOSTICS LTD (Scrip Code: 540788). The takeover offer at Rs. 55.00 per share for up to 26,76,180 shares represents a significant liquidity event for existing shareholders. Trading members must ensure operational readiness on the iBBS and RTRMS platforms for the two-week offer window. Eligible investor categories include FII, FI, MF, IC, OTH, NOH, CO, and IND. Members should take note of the strict no-modification/cancellation policy and the differing session end times on the final day.</p>
]]></content:encoded></item></channel></rss>